Patents for A61K 31 - Medicinal preparations containing organic active ingredients (785,912) |
---|
03/14/2012 | CN102370651A Inhaled pharmaceutical composition containing eplerenone and ciclesonide as active components |
03/14/2012 | CN102370650A Compound triamcinolone acetate-urea cream and preparation method thereof |
03/14/2012 | CN102370649A YycG histidine kinase activity of bacterial signal transduction system |
03/14/2012 | CN102370648A Medicinal composition and its application |
03/14/2012 | CN102370647A Application of dexrazoxane as antioxidant |
03/14/2012 | CN102370646A Substance for protecting heart |
03/14/2012 | CN102370645A Anticancer drug composition |
03/14/2012 | CN102370644A Nifedipine medicine composition and preparation method thereof |
03/14/2012 | CN102370643A Berberine hydrochloride medicinal composition and preparation method thereof |
03/14/2012 | CN102370642A Amoxicillin medicinal composition and preparation method thereof |
03/14/2012 | CN102370641A Animal ectoparasite-controlling agent |
03/14/2012 | CN102370640A Compound amino acid preparation for hemodialysis and hemodialysis preparation containing same |
03/14/2012 | CN102370639A Compound preparation of naproxen and sumatriptan |
03/14/2012 | CN102370638A Application of 3,3'-diindolylmethane and 3,3'-diindolylmethane derivatives in preparation of drugs for treating liver diseases |
03/14/2012 | CN102370637A Application of atorvastatin in preparation of drug for promoting mesenhymal stem cell surviving in vivo and mesenhymal stem cell differentiation into myocardial cells |
03/14/2012 | CN102370636A Application of simvastatin for promoting bone marrow-derived mesenchymal stem cell survival and differentiation towards cardiomyocyte |
03/14/2012 | CN102370635A Application and preparation method of novel nardosinone |
03/14/2012 | CN102370634A Application of epigallocatechin gallate |
03/14/2012 | CN102370633A Bacterial YycG histidine kinase inhibitor |
03/14/2012 | CN102370632A Application of SIRT1 micro-molecular inhibitor in preparation of medicines for treating or preventing caner and protein deacetylation related diseases |
03/14/2012 | CN102370629A Entecavir liquid capsule and preparation method thereof |
03/14/2012 | CN102370628A Tetra-acetylated puerarin self-microemulsified sustained-release double-layer tablet and preparation method thereof |
03/14/2012 | CN102370627A Norfloxacin medical composition and preparation method thereof |
03/14/2012 | CN102370625A Felodipine tablets |
03/14/2012 | CN102370622A Medicament carrying nano particles and preparation method and application thereof |
03/14/2012 | CN102370621A Solid preparation with cefotiam hexetil as active component |
03/14/2012 | CN102370620A Pulmonic targeting immuno nano liposome and preparation method thereof |
03/14/2012 | CN102370619A Fat-emulsion-emulsified local anesthetic |
03/14/2012 | CN102370618A Emulsion containing Temodal, preparation technology thereof and purpose thereof |
03/14/2012 | CN102370617A Ophthalmic huperzine A microemulsion and preparation method thereof |
03/14/2012 | CN102370616A Rifampicin nano-grade suspension and preparation method thereof |
03/14/2012 | CN102370615A 一种布洛芬注射制剂及其制备方法 One kind of injectable formulation of ibuprofen and its preparation method |
03/14/2012 | CN102370614A Polar medicine |
03/14/2012 | CN102370613A Lidocaine hydrochloride transdermal ointment and preparation method thereof |
03/14/2012 | CN102370610A Anti-allergy medicine gel and preparation method thereof |
03/14/2012 | CN102370401A Traditional Chinese medicine medicated pillow for treating cervical spondylosis and preparation method thereof |
03/14/2012 | CN102370395A Chinese medicinal health-care pillow and manufacturing method thereof |
03/14/2012 | CN102133384B Ginger and dried orange peel composition, preparation method thereof and application of ginger and dried orange peel composition in preparation of attenuated synergistic medicaments in cancer radiotherapy and chemotherapy |
03/14/2012 | CN102119974B Externally-applied medicinal liquor |
03/14/2012 | CN102028694B Application of Fasudil in preparing medicaments for treating glaucoma through ophthalmic drug delivery |
03/14/2012 | CN101984997B Anti-tumor composition containing four-substance decoction extract and application thereof |
03/14/2012 | CN101953851B Pills for treating pharyngitis, furuncle and carbuncle and ulcers and preparation method thereof |
03/14/2012 | CN101941982B Novel preparation method of pharmaceutical ceforanide |
03/14/2012 | CN101940566B Application and preparation of bitter orange extract meranzin hydrate for preparing enterocinetic kinetic medicaments |
03/14/2012 | CN101904859B Rhoifolin and hyperin composition and application of medicines prepared therefrom |
03/14/2012 | CN101891705B 4-alkyl-6-aryl-2-acylamino-1,3-thiazine-5-formic ether, and preparation method and application thereof |
03/14/2012 | CN101856383B Liver-protecting white spirit and preparation method thereof |
03/14/2012 | CN101843629B New application of icariin and epimedium flavone containing icariin |
03/14/2012 | CN101843623B External fat-increasing preparation and application thereof |
03/14/2012 | CN101836952B Ambroxol injection and preparation method thereof |
03/14/2012 | CN101804053B Chiral benzo-quinoline hydrochloride-2-carboxylic acid arginine salt composite and preparation and application thereof |
03/14/2012 | CN101773480B Preparation method of Nnanocrystal preparation containing docetaxelDuoxitasai and method for preparing a freeze-drying agent thereof |
03/14/2012 | CN101712671B Daizeol aliphatic ester derivatives, preparing method and medical application thereof |
03/14/2012 | CN101712658B 1-butyl-2-hydroxy aralkyl piperazine derivative and application as antidepressant |
03/14/2012 | CN101708238B Preparation method of qingkailing syrup |
03/14/2012 | CN101703494B Transdermal nitrendipine adhesive patch and preparation method thereof |
03/14/2012 | CN101627983B Medicinal composition for inhibiting angiogenesis and application thereof |
03/14/2012 | CN101575336B N-aryl piperazine derivative and preparation method thereof and drug composition adopting N-aryl piperazine derivative as active ingredient |
03/14/2012 | CN101564388B Composition for Danshensu and danshinolic acid B and use thereof |
03/14/2012 | CN101563328B Substituted heteroaryl pyridopyrimidone derivatives |
03/14/2012 | CN101528925B Dbait and uses thereof |
03/14/2012 | CN101506201B Novel heteroaryl substituted benzoxazoles |
03/14/2012 | CN101496806B Use of compound extracted from bitter melon in preparing medicament for preventing and treating diabetes and fat disease |
03/14/2012 | CN101484448B Pyrazole alkanamide substituted thiophenes as AMPA potentiators |
03/14/2012 | CN101450963B Gourd alkane type triterpene saponin compounds, medicament composition thereof as well as preparation method and application thereof |
03/14/2012 | CN101450216B Medicine for preventing hyperplastic scar fibroblast proliferation |
03/14/2012 | CN101450074B Composition capable of greatly improving gastrointestinal tract function and preventing and treating astriction |
03/14/2012 | CN101442998B Anti-cancer activity augmentation compounds and formulations and methods of use thereof |
03/14/2012 | CN101439064B Nourishing tonic for sport |
03/14/2012 | CN101437509B Acidic composition |
03/14/2012 | CN101426790B Novel 1,4-diaza-bicyclo[3.2.2]nonyl oxadiazolyl derivatives and their medical use |
03/14/2012 | CN101417061B Traditional Chinese medicine for treating folliculitis and preparation method thereof |
03/14/2012 | CN101384264B Therapeutic combinations comprising poly (adp-ribose) polymerases inhibitor |
03/14/2012 | CN101366716B Application of Raloxifene compounds in preparing medicament for preventing and controlling benign prostatahyperplasie |
03/14/2012 | CN101361739B Anti-bacteria agent for parenteral administration |
03/14/2012 | CN101360502B Crystalline forms |
03/14/2012 | CN101360495B Administration of mntor inhibitor to treat patients with cancer |
03/14/2012 | CN101312963B Glucagon receptor antagonists, preparation and therapeutic uses |
03/14/2012 | CN101306014B Use of brown algae polysaccharide sulfuric acid ester of low molecular weight in preparing medicine for treating diabetic nephropathy |
03/14/2012 | CN101291933B Derivatives of 5-pyridazinyl-1-azabicyclo[3.2.1]octane, preparation method thereof and use of same in therapeutics |
03/14/2012 | CN101284016B Bezoar vitro bred and solid oral preparation containing the bezoar |
03/14/2012 | CN101284008B IL-4R antagonist and microorganism for generating the IL-4R antagonist |
03/14/2012 | CN101272782B Novel triazole derivatives as ghrelin analogue ligands of growth hormone secretagogue receptors |
03/14/2012 | CN101212966B Process for synthesizing a CETP inhibitor |
03/14/2012 | CN101098686B Glycogen synthase kinase-3 inhibitors |
03/14/2012 | CN101096359B Polyaryl substituted methane oxygen or silica radical guanidine compound and preparation method and usage thereof |
03/14/2012 | CN101039585B Mixture of phytosterol ester(s) and 1,3-diglyceride(s) for use in the treatment of medical conditions |
03/14/2012 | CN101001858B S-tenatoprazole sodium monohydrate salt and the use thereof in the form of a proton pump inhibitor |
03/13/2012 | USRE43244 Phenylethylamines and condensed rings variants as prodrugs of catecholamines, and their use |
03/13/2012 | US8134029 Treatment of CNS disorders with trans 4-(3,4-dichlorophenyl)-1,2,3,4-tetrahydro-1-napthalenamine |
03/13/2012 | US8134017 Compound and use thereof |
03/13/2012 | US8134013 Amide compound and thrombopoietin receptor activator |
03/13/2012 | US8134010 4-[4-Methyl-5-(2-nitrooxy-ethyl)-thiazol-2-yl]-phenylamine; N-{4-[4-Methyl-5-(2-nitrooxy-ethyl)-thiazol-2-yl]-phenyl}-acetamide; or4-Methyl-5-(2-nitrooxy-ethyl)-2-(4-nitro-phenyl)-thiazole; cardiovascular, gastrointestinal, inflammatory, respiratory disease |
03/13/2012 | US8134008 Preparation of amorphous hydrous esomeprazole magnesium |
03/13/2012 | US8134007 Pyridine derivatives |
03/13/2012 | US8134001 Spiroindolinone derivatives |
03/13/2012 | US8133995 Substituted 4-amino-pyrrolotriazine derivatives useful for treating hyper-proliferative disorders and diseases associated with angiogenesis |
03/13/2012 | US8133992 Azepinoindole and pyridoindole derivatives as pharmaceutical agents |
03/13/2012 | US8133991 cellulose ether or starch ether with a hydroxyalkyl or polyoxyethylene group; aerosol sprayed on a mask; floor wipes; nonwoven sheet |
03/13/2012 | US8133983 Agonistic binding molecules to the human OX40 receptor |